Latest revenue
$70.8M
as of 2026-03-31
Latest net income
$-110.6M
as of 2026-03-31
Net margin
-156.3%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $95.3M
- Enterprise value
- $95.3M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $4.29
- 52-wk low
- $0.96
- Beta
- —
- Shares out
- 73.9M
5-year trend
What this company does
Table of Contents Item 1. Business Overview We are a leading provider of data and analytics technology and services to healthcare organizations. Our Solution comprises our cloud-based data and analytics platform, software applications, and expertise. Our clients, which are primarily healthcare providers, use our Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements. We envision a future where all healthcare decisions are data-informed. The Health Catalyst Way Our Mission Our mission is to be the catalyst for massive, measurable, data-informed healthcare improvement. We fulfill our…
AI summary unavailable — showing raw filing excerpt
Generated from HCAT's filing dated 2026-03-12
Key risks
Table of Contents Item 1A. Risk Factors You should carefully consider the following risk factors, in addition to the other information contained in this Annual Report on Form 10-K, including the section of this report titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and related notes. If any of the events described in the following risk factors and the risks described elsewhere in this report occurs, our business, operating results and financial condition could be seriously harmed. This Annual Report on Form 10-K also contains forward-looking statements that involve risks and uncertainties. Our actual results could…
AI summary unavailable — showing raw filing excerpt
Generated from HCAT's filing dated 2026-03-12
Profitability
Operating margin
-51.7%
127.1%Net margin
-57.2%
152.3%Return on equity
-72.4%
282.3%Return on assets
-35.4%
337.6%Leverage
Debt / equity
1.05×
22.1%Long-term debt / equity
0.62×
49.7%Debt / assets
51.1%
10.8%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $70.8M | -10.9% | $-110.6M | -370.1% | -156.3% |
Q4 2025 2025-12-31 | $74.7M | -6.2% | $-91.4M | -338.1% | -122.3% |
Q3 2025 2025-09-30 | $76.3M | -0.0% | $-22.2M | -50.7% | -29.1% |
Q2 2025 2025-06-30 | $80.7M | +6.3% | $-40.9M | -204.2% | -50.7% |
Q1 2025 2025-03-31 | $79.4M | +6.3% | $-23.5M | -14.9% | -29.6% |
Q4 2024 2024-12-31 | $79.6M | — | $-20.9M | — | -26.2% |
Q3 2024 2024-09-30 | $76.4M | +3.5% | $-14.7M | +33.0% | -19.3% |
Q2 2024 2024-06-30 | $75.9M | +3.7% | $-13.4M | +58.7% | -17.7% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Computer Programming, Data Processing, Etc. · SIC 7370
Your notes
Keep private notes on HCAT — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$245.3K
Net activity
−$245.3K
Distinct insiders
2
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns HCAT
Institutional value
$26.3M
Total shares held
20.9M
Distinct holders
80
-55 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.1M | $6.5M | -55.1K (-1.1%) | Trimmed |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 2.9M | $3.7M | — | New |
| 3 | Impax Asset Management Group plc | 2.8M | $3.5M | +0 (+0.0%) | No change |
| 4 | Nepsis Inc. | 1.9M | $2.4M | -39.5K (-2.1%) | Trimmed |
| 5 | DIMENSIONAL FUND ADVISORS LP | 1.2M | $1.6M | -406.7K (-24.8%) | Trimmed |
| 6 | HighMark Wealth Management LLC | 903.1K | $1.1M | +161.6K (+21.8%) | Added |
| 7 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 710.8K | $902.7K | +397.5K (+126.9%) | Added |
| 8 | JPMORGAN CHASE & CO | 677.9K | $800.0K | -74.9K (-9.9%) | Trimmed |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 531.0K | $674.4K | — | New |
| 10 | KENNEDY CAPITAL MANAGEMENT LLC | 509.8K | $647.4K | -455.0K (-47.2%) | Trimmed |
| 11 | VANGUARD FIDUCIARY TRUST CO | 443.7K | $563.5K | — | New |
| 12 | PRIMECAP MANAGEMENT CO/CA/ | 340.4K | $432.3K | +0 (+0.0%) | No change |
| 13 | 71 West Capital Partners | 339.5K | $431.2K | +179.5K (+112.1%) | Added |
| 14 | UBS Group AG | 287.1K | $364.6K | +23.6K (+9.0%) | Added |
| 15 | Bank of New York Mellon Corp | 266.7K | $338.6K | +444 (+0.2%) | Added |
| 16 | DEUTSCHE BANK AG\ | 224.5K | $285.1K | -36.8K (-14.1%) | Trimmed |
| 17 | Nuveen, LLC | 184.4K | $234.2K | +60.7K (+49.1%) | Added |
| 18 | Vanguard Global Advisers, LLC | 173.2K | $219.9K | — | New |
| 19 | SEI INVESTMENTS CO | 169.3K | $215.0K | +73.4K (+76.6%) | Added |
| 20 | Invesco Ltd. | 118.1K | $150.0K | -461 (-0.4%) | Trimmed |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once HCAT's latest filing finishes processing.